ClinicalTrials.Veeva

Menu

Prospective Randomized, Controlled Trial for Treatment of Intraventricular Hemorrhage (IVH)

Albany Medical College logo

Albany Medical College

Status

Unknown

Conditions

Intraventricular Hemorrhage

Treatments

Procedure: endoscopic hematoma evacuation
Procedure: Rt-PA thrombolysis

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Intraventricular hemorrhage comprises about 15% of the 500,000 strokes that occur annually in the United States. In the emergent setting, patients with obstructive hydrocephalus are routinely treated with placement of an external ventricular drain. This study will compare the effect of external ventricular drainage plus intraventricular thrombolysis versus external ventricular drainage plus endoscopic evacuation on neurologic outcomes for patients with hydrocephalus from intraventricular hemorrhage.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-75
  • Radiographic evidence of intraventricular hemorrhage with hydrocephalus
  • Admission Glasgow Coma Scale ≥ 5 (motor score ≥ 2)
  • Placement of an external ventricular drain with an opening pressure >20 mm Hg

Exclusion criteria

  • Intraventricular hemorrhage secondary to cerebral aneurysm, arteriovenous malformation, or tumor

  • Coagulopathy (Platelet count <100,000, International normalized ratio >1.5. Reversal of warfarin is permitted.)

  • Age <18 or >75

  • Pregnancy (positive pregnancy test)

  • Clotting disorders

  • Medical contraindications to administration of general anesthesia as determined by the attending anesthesiologist

  • Medical contraindications to surgery as determined by the attending neurosurgeon

  • Contraindication to recombinant tissue plasminogen activator administration:

    • Evidence of enlargening intracranial hemorrhage as evidenced by an increase in intracranial hemorrhage volume (>5 ml) on CT obtained after EVD placement
    • Internal bleeding, involving retroperitoneal sites, or the gastrointestinal, genitourinary, or respiratory tracts
    • Superficial or surface bleeding, observed at vascular puncture and access sites (e.g. venous cutdowns, arterial punctures) or site of recent surgical intervention
  • Evidence of cerebrospinal infection by Gram stain or culture

  • Advanced directive indicating Do Not Resuscitate or Do Not Intubate status

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

34 participants in 2 patient groups

External Ventricular drainage, Intraventricular Thrombolysis
Other group
Treatment:
Procedure: Rt-PA thrombolysis
External Ventricular Drainage and Endoscopic Evacuation
Other group
Treatment:
Procedure: endoscopic hematoma evacuation

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Hung Kuo, MD; Tyler Kenning, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems